N-MYC–eIF4G1 Axis Drives Survival in inv(16) Acute Myeloid L
2026-07-31
Peramangalam et al. uncover a novel mechanism in inv(16) acute myeloid leukemia (AML) where N-MYC, upregulated by a unique enhancer, sustains leukemic cell survival through direct regulation of eIF4G1. This discovery highlights a previously uncharacterized oncogenic axis and provides a rationale for targeting N-MYC/eIF4G1 interactions in AML therapeutics.
Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In
2026-07-31
Wang et al. (2018) systematically identified that genotype III grass carp reovirus (GCRV104) enters host cells via clathrin-mediated, dynamin-dependent endocytosis, using a comprehensive inhibitor profiling approach. Their findings clarify the mechanistic basis of GCRV cellular entry and inform the specificity limits of cytoskeletal disruption agents, such as Latrunculin B, in aquatic virology research.
Phosphotungstic Acid Negative Stain Solution: Imaging Advanc
2026-07-30
Phosphotungstic Acid Negative Stain Solution (2%) empowers electron microscopists to capture high-contrast, detailed images of viruses, macromolecules, and glycoproteins. Explore advanced workflows, troubleshooting strategies, and translational applications that leverage this optimized stain for breakthrough virology and structural biology research.
Birinapant (TL32711): Precision Apoptosis Induction in Cance
2026-07-30
Birinapant (TL32711) enables researchers to overcome apoptosis resistance in cancer models by targeting IAPs and enhancing therapeutic sensitivity. This guide details experimental workflows, troubleshooting strategies, and biomarker-driven insights that leverage Birinapant’s unique mechanism for robust, reproducible apoptosis research.
Structure-Based Inhibitor Discovery for SARS-CoV-2 NSP15
2026-07-29
This study utilized structure-based virtual screening of natural products to identify potent inhibitors of the SARS-CoV-2 NSP15 endoribonuclease, highlighting thymopentin and oleuropein as promising candidates. These findings inform new strategies for antiviral drug development by targeting viral immune evasion mechanisms.
Tioconazole in Antifungal Drug Development: Workflows & Solu
2026-07-29
Tioconazole stands out as a gold-standard antifungal medication for dissecting ergosterol biosynthesis and optimizing fungal infection models. This article delivers actionable protocols, comparative insights, and troubleshooting strategies to empower high-fidelity antifungal research with APExBIO’s Tioconazole.
Linarin From Herba Patriniae Induces Cell Cycle Arrest in NS
2026-07-28
The referenced study identifies Linarin, a core active compound from Herba Patriniae, as an inhibitor of non-small-cell lung cancer (NSCLC) cell proliferation. Through network pharmacology and rigorous in vitro validation, Linarin was shown to induce G0/G1 cell cycle arrest, senescence, and apoptosis by downregulating Cyclin A2/B1 and CHEK1, offering new mechanistic insight and a potential complementary therapy for NSCLC.
Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for Advanced
2026-07-28
Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables high-fidelity RNA probe synthesis and direct visualization in complex molecular biology workflows. This article uniquely bridges mechanistic insight, protocol optimization, and immune pathway research for next-generation RNA labeling applications.
EAGLE-2 & EAGLE-3: Gepotidacin for Uncomplicated UTI—Trial I
2026-07-27
The EAGLE-2 and EAGLE-3 phase 3 trials rigorously evaluated the efficacy and safety of oral gepotidacin versus nitrofurantoin in adolescent and adult females with uncomplicated urinary tract infections. This research demonstrates gepotidacin’s non-inferiority—and in one trial, superiority—to standard therapy, representing a significant advance in the pursuit of effective oral agents against resistant uropathogens.
Sulfo-Cy5 NHS Ester: Innovations in Fluorescent Protein Labe
2026-07-27
Explore how Sulfo-Cy5 NHS ester enables advanced, quenching-resistant fluorescent protein conjugation in challenging aqueous environments. This article reveals scientific insights and practical protocols for maximizing the value of Sulfo-Cyanine5 Succinimidyl Ester in cutting-edge imaging and immuno-oncology research.
CircRHOBTB3 Restricts Prostate Cancer via NONO and MAOA Modu
2026-07-26
This study identifies circRHOBTB3 as a tumor-suppressive circular RNA in prostate cancer, functioning by promoting cytoplasmic retention of NONO and thereby suppressing MAOA transcription. These findings reveal a novel regulatory axis with implications for biomarker development and therapeutic targeting in metastatic prostate cancer.
ML385 and NRF2 Inhibition: Beyond Cancer Resistance to Neuro
2026-07-25
Explore how the NRF2 inhibitor ML385 advances research from cancer therapy resistance to neuronal ferroptosis and cognitive decline. Discover unique assay insights, protocol parameters, and translational applications.
Machine Learning Discovery of Senolytics: Advances and Impli
2026-07-24
The referenced study demonstrates a machine learning-driven strategy to identify new senolytic agents, addressing the scarcity of well-characterized compounds that selectively eliminate senescent cells. This approach not only validates novel candidates but also reduces drug screening costs, providing a pathway for rapid senolytic discovery across disease models.
Pesticide Spray Drift: UAV vs. Knapsack Sprayer Quantificati
2026-07-24
This study provides the first rigorous field-based comparison of pesticide spray drift characteristics between unmanned aerial vehicle (UAV) sprayers and traditional electric knapsack sprayers (EKS), using Rhodamine B as a fluorescent tracer. The findings highlight UAVs' significantly greater drift potential and deposition rates, offering critical data for environmental risk assessment and the development of regulatory guidelines for UAV pesticide application.
Protease Inhibitor Cocktail EDTA-Free: Precision in Protein
2026-07-23
The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) from APExBIO delivers uncompromising protein integrity for EDTA-sensitive applications. Its robust, broad-spectrum inhibition empowers advanced workflows from phosphorylation analysis to high-complexity immunoprecipitation, with clear protocol advantages and troubleshooting strategies for demanding research environments.
459 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page